StockTipsArenaBeta

BUY Aurobindo Pharma — Siddharth Rai Mangala

BUYAurobindo Pharma
Aurobindo Pharma share price target & all analyst calls

bySiddharth Rai MangalaHorizon: NA (inferred Intraday)25 Aug 2026, 2:23 pm ISTvia Zee Business (Live)

Entry₹1,621.6Inferred
Target₹1,648
Total upside +1.63% (call closed)
Stop loss₹1,605-1.02% risk
At expiry₹1,614.925 Aug 2026, 3:05 pm
Expired-0.41%
Follow Siddharth Rai Mangala for new calls(15% target hit, 136 closed calls)Get alertsWatch AUROPHARMA for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 25 Aug 2026
2 supporting1 neutral1 opposing
Supports the BUY call (2)

Aurobindo Pharma Share Price Gains As USFDA Concludes Inspection At Subsidiary Lannett's Unit

NewsNdtv-Profit·24 Aug · yesterday

(opens in new tab)

Aurobindo Pharma US FDA inspection ends with one observation at AuroPeptides facility

NewsCnbc-Tv18·21 Aug · 3d ago

(opens in new tab)
Neutral / worth noting (1)

Here's why these four pharma stocks are in focus today

NewsCnbc-Tv18·24 Aug · yesterday

(opens in new tab)
Weighs against the BUY call (1)

Aurobindo Pharma US subsidiary Lannett Company LLC faces 4 observations from the USFDA

NewsLivemint·24 Aug · yesterday

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aurobindo Pharma

All analyst calls on Aurobindo Pharma

More from Siddharth Rai Mangala

Every call and its outcome